However, in patients with metachronous BM development, the difference in BM-OS between patients with EGFR MT (14.6 months) and EGFR WT (2.5 months) did not reach statistical significance ( p = 0.230).
← all excerpts
Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer.
1
0.2300
0.2300